HAPPYMINI
HAPPYMINI® in the treatment of Temporo-Mandibular Osteoarthritis

HAPPYMINI® in the treatment of Temporo-Mandibular Osteoarthritis

  This prospective pilot study was conducted to show the Safety & Efficacy of a Single Injection of Mannitol-modified Cross-Linked Hyaluronic Acid (HAppyMini®) in the treatment of the Temporo-Mandibular Osteoartritis.   Results  at D180 : Treatment was efficient or very efficient for 94% of the patients Long lasting improvment of the inter-incisal distance  2/3 of patients reduced their painkillers / NSAIDs intake   UNIQUE COMBINATION...
Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked HA in Patients with Trapeziometacarpal OA.

Safety and Predictive Factors of Short-Term Efficacy of a Single Injection of Mannitol-Modified Cross-Linked HA in Patients with Trapeziometacarpal OA.

    Like every year since 2012, LABRHA attended the EULAR Annual Meeting which took place in Amsterdam from the 13th  to the 16th of June 2018.      During the scientific session on « OSTEOARTHRITIS and microcrystalline disease », Dr Thierry CONROZIER (France) presented results of the INSTINCT Study: influence of the radiological grade on the efficacy of an intra-articular injection of...
LABRHA at the ISIAT Congress in Prague in October 2017

LABRHA at the ISIAT Congress in Prague in October 2017

The 4th edition of the International Symposium on Intra-Articular Treatment (ISIAT) took place in Prague last 5th to 7th of October 2017. Organized every two years across different European cities by Prof. Alberto Migliore (IT), this congress is, as its name suggests, focus on intra-articular management of joint disease including intra-articular access, therapeutic targets and...
Addition of a Polyol to HA: a Significant Advance in the Treatment of Osteoarthritis?

Addition of a Polyol to HA: a Significant Advance in the Treatment of Osteoarthritis?

Is the addition of a polyol to hyaluronic acid a significant advance in the treatment of osteoarthritis? Conrozier T. Curr Rheumatol Rev. 2017 Jul 10. doi:10.2174/1573397113666170710115558. Viscosupplementation with intra-articular injections of hyaluronic acid is recommended as a second line treatment for knee OA, after failure of non-pharmacological modalities and usual pain killers. Nevertheless there is...
LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA at the OARSI Congress in Las Vegas in April 2017

LABRHA participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. . 1) HAppyMini® in the Trapeziometacarpal joint: first results presented at the OARSI Congress . The abstract SAFETY AND EFFICACY OF A SINGLE INJECTION OF MANNITOL-MODIFIED CROSSLINKED HYALURONIC ACID (HAppyMini®) IN TRAPEZIOMETACARPIAL...